Exploring The Data Challenge And Its Effect On AI Implementation In Healthcare And Life Sciences

  |   Artificial Intelligence   |   No comment

The Data Challenge: A Major Hurdle for AI in Healthcare


The vast potential of Artificial Intelligence (AI) in healthcare is undeniable in contemporary medical practices. However, its implementation often encounters significant obstacles, primarily due to prevailing data challenges that exacerbate technical and methodological issues. As advanced solutions like Big Data Management and AI-driven Predictive Analytics come to the fore, clinicians are hindered by the lack of high-quality medical data.


Researchers typically require high-quality datasets to validate AI Models, but they often lack access to standardized medical data. This data tends to be significantly fragmented across electronic health records and software platforms, and incompatibility between multiple organizations or data sources further restricts the usefulness of raw statistics and information. According to a 2019 HIMSS Media research report, only 36% of systems are capable of automatically recognizing terminology, medical symbols, and coding values.


Impact of Data Issues on AI in Life Sciences


Due to the aforementioned reasons, the performance metrics of AI become largely irrelevant as they cannot be seamlessly applied to clinical settings. However, the data challenge extends to foundational issues in research methodology, where available literature is limited to historical patient accounts. Consequently, the application and true value of AI in healthcare are significantly hindered by existing data discrepancies and privacy issues. Addressing these issues is crucial to facilitate future research and unlock the potential of AI in real-world settings.


Dealing with vast sets of highly sensitive, private, or confidential patient data, AI-enabled data management faces issues of data security, primarily due to unauthorized access. In addition, an over-reliance on non-representative data has resulted in significant data bias, leading to inaccurate reports, particularly for marginalized communities. Consequently, the stark data dilemma surrounding AI implementation in healthcare raises ethical considerations related to informed consent, transparency, and accountability, especially in a scenario where regulatory safeguards are lacking.


The Interplay Between Data Dilemmas and AI in Healthcare and Life Sciences


Specifically, existing regulatory frameworks such as the Health Insurance Portability and Accountability Act (HIPAA) have often fallen short in effectively monitoring precarious situations, such as genetics testing companies selling customer data to biotech and pharma firms, or insurance companies using genetic data, potentially leading to unfair selection. Incidents of data breaches, algorithmic bias, and issues concerning competition and intellectual property further amplify the challenges of incomplete data and unclear documentation and reporting practices.


Given that the majority of life sciences data is unstructured, unclean, and highly regulated, the data dilemma has led to significant regulatory and operational challenges. As stated by NTT Data, “There is a lot of data to be harnessed, and top life sciences companies have taken notice. With rapid reductions in the costs of genome sequencing, the amount of genomic data has skyrocketed to over 40 exabytes over the past decade.”


Indeed, in most cases, life sciences data is not appropriately cleansed or formatted. It often comes in the form of typed MSL reports and field team observations, which can vary greatly in format, length, and even language. The problem has been compounded as many organizations have not yet fully transitioned to Electronic Medical Records (EMRs). 


As a result, this produces inconsistent and disparate data streams that impede the effectiveness of AI in life sciences. In this regard, it may be pertinent to recall a statement released by Deloitte, “While most companies are embracing new technologies to deliver enhanced patient outcomes, the ambiguity of regulations related to converging and emerging technologies results in a myriad of compliance challenges.


Unpacking the Data Problem: Implications for AI in Healthcare and Life Sciences



Despite the ongoing data challenges, the integration of AI in healthcare and life sciences holds multiple implications. It’s crucial to acknowledge that these challenges might temporarily delay the full utilization of AI in the healthcare sector, due to constraints in the development of AI models, unreliable or inaccurate predictions, and incomplete AI learnings and outcomes, among other things. Additionally, it might prove difficult to eliminate the disparities that disadvantage marginalized groups.


Data interoperability and standardization is an urgent need for medical researchers and practitioners. Specifically, this can be ensured through the adoption of suitable coding systems and ontologies to facilitate smooth data integration and sharing, as well as the creation of comprehensive datasets. In this context, it’s crucial to strike an ideal balance between research potential and privacy concerns. This could be accomplished through controlled and properly supervised access to large datasets.


Leaning towards open-source or public data that aligns with existing records could act as a supplementary source of information for AI applications. This could help ensure inclusive representation in training data, leveraging innovative strategies for data manipulation while utilizing cloud-based capabilities for parallel processing. The future indeed holds promising prospects, as initiatives and organizations like the Cancer Genome Atlas are committed to tackling data scarcity in this domain by hosting anonymized medical data publicly. Overall, such approaches could help resolve many other issues like the transportation and processing of large-sized data.

No Comments

Post A Comment